Product insert fails to identify performance limitation related to EUCAST breakpoints for Teicolplanin.
Source facts
Action
Biomerieux sent an Urgent Product Correction Notice letter via email on February 24, 2016 to affected customers . The letter identified the affected product, problem and actions to be taken. Customers were asked to complete the attached Acknowledgement Form (Attachment A) and return it to Biomerieux, Inc. For questions contact your local bioMrieux representative.
Initiated
2016-02-24
Root cause
Labeling Change Control
Terminated
2018-03-08
Distribution
Foreign distribution in the countries of Czech Republic, Hong Kong (China), Hungary, Japan, Poland, South Africa, Switzerland, and Turkey.
Recall number
Z-1640-2016
Recall status
Terminated
CDRH record ID
144597
FDA classified
2016-05-11
Recall event number
73413
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.